These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 8096076

  • 1. Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity.
    Smith K, Houlbrook S, Greenall M, Carmichael J, Harris AL.
    Oncogene; 1993 Apr; 8(4):933-8. PubMed ID: 8096076
    [Abstract] [Full Text] [Related]

  • 2. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
    Järvinen TA, Tanner M, Bärlund M, Borg A, Isola J.
    Genes Chromosomes Cancer; 1999 Oct; 26(2):142-50. PubMed ID: 10469452
    [Abstract] [Full Text] [Related]

  • 3. Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy.
    Harris LN, Yang L, Liotcheva V, Pauli S, Iglehart JD, Colvin OM, Hsieh TS.
    Clin Cancer Res; 2001 Jun; 7(6):1497-504. PubMed ID: 11410482
    [Abstract] [Full Text] [Related]

  • 4. Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer.
    Orlando L, Del Curto B, Gandini S, Ghisini R, Pietri E, Torrisi R, Balduzzi A, Cardillo A, Dellapasqua S, Veronesi P, Viale G, Goldhirsch A, Colleoni M.
    Breast; 2008 Oct; 17(5):506-11. PubMed ID: 18456496
    [Abstract] [Full Text] [Related]

  • 5. Gene copy mapping of the ERBB2/TOP2A region in breast cancer.
    Jacobson KK, Morrison LE, Henderson BT, Blondin BA, Wilber KA, Legator MS, O'Hare A, Van Stedum SC, Proffitt JH, Seelig SA, Coon JS.
    Genes Chromosomes Cancer; 2004 May; 40(1):19-31. PubMed ID: 15034864
    [Abstract] [Full Text] [Related]

  • 6. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL, Rosenthal SI, Brien TP, Stylos S, Johnson RL, Ross JS.
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.
    Harris LN, Yang L, Tang C, Yang D, Lupu R.
    Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.
    Di Leo A, Gancberg D, Larsimont D, Tanner M, Jarvinen T, Rouas G, Dolci S, Leroy JY, Paesmans M, Isola J, Piccart MJ.
    Clin Cancer Res; 2002 May; 8(5):1107-16. PubMed ID: 12006526
    [Abstract] [Full Text] [Related]

  • 12. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
    Asano T, An T, Zwelling LA, Takano H, Fojo AT, Kleinerman ES.
    Oncol Res; 1996 May; 8(3):101-10. PubMed ID: 8823806
    [Abstract] [Full Text] [Related]

  • 13. Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
    Tortora G, Ciardiello F, Damiano V, Pepe S, Bianco C, di Isernia G, Davies SL, North P, Harris AL, Hickson ID.
    Clin Cancer Res; 1995 Jan; 1(1):49-56. PubMed ID: 9815886
    [Abstract] [Full Text] [Related]

  • 14. Expression of topoisomerase IIalpha is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer.
    Järvinen TA, Kononen J, Pelto-Huikko M, Isola J.
    Am J Pathol; 1996 Jun; 148(6):2073-82. PubMed ID: 8669491
    [Abstract] [Full Text] [Related]

  • 15. Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells?
    Tang RP, Kacinski B, Validire P, Beuvon F, Sastre X, Benoit P, dela Rochefordière A, Mosseri V, Pouillart P, Scholl S.
    J Cell Biochem; 1990 Nov; 44(3):189-98. PubMed ID: 1980125
    [Abstract] [Full Text] [Related]

  • 16. Correlation between DNA topoisomerase II activity and cytotoxicity in pMC540 and merodantoin sensitive and resistant human breast cancer cells.
    Sharma R, Arnold L, Gulliya KS.
    Anticancer Res; 1995 Nov; 15(2):295-304. PubMed ID: 7762997
    [Abstract] [Full Text] [Related]

  • 17. Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.
    Bièche I, Tomasetto C, Régnier CH, Moog-Lutz C, Rio MC, Lidereau R.
    Cancer Res; 1996 Sep 01; 56(17):3886-90. PubMed ID: 8752152
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a DNA topoisomerase IIalpha gene rearrangement in adriamycin-resistant P388 leukemia: expression of a fusion messenger RNA transcript encoding topoisomerase IIalpha and the retinoic acid receptor alpha locus.
    McPherson JP, Brown GA, Goldenberg GJ.
    Cancer Res; 1993 Dec 15; 53(24):5885-9. PubMed ID: 8261398
    [Abstract] [Full Text] [Related]

  • 19. Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples.
    Mueller RE, Parkes RK, Andrulis I, O'Malley FP.
    Genes Chromosomes Cancer; 2004 Apr 15; 39(4):288-97. PubMed ID: 14978790
    [Abstract] [Full Text] [Related]

  • 20. [Amplification and overexpression of c-erbB2 in human breast cancer].
    Chen Y, Dong J, Li C.
    Zhonghua Zhong Liu Za Zhi; 1995 Jan 15; 17(1):16-9. PubMed ID: 7656779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.